Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
87.66
+1.57 (1.82%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of $5.60 billion as of April 25, 2025. Its market cap has decreased by -0.77% in one year.
Market Cap
5.60B
Enterprise Value
5.41B
1-Year Change
-0.77%
Ranking
Category
Stock Price
$87.66
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from $469.40M to $5.60B, an increase of 1,093.44%. That is a compound annual growth rate of 28.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 5.50B | -0.70% |
| Dec 31, 2024 | 5.54B | -1.19% |
| Dec 29, 2023 | 5.61B | 113.92% |
| Dec 30, 2022 | 2.62B | -58.41% |
| Dec 31, 2021 | 6.30B | 0.83% |
| Dec 31, 2020 | 6.25B | 58.57% |
| Dec 31, 2019 | 3.94B | 66.35% |
| Dec 31, 2018 | 2.37B | -19.85% |
| Dec 29, 2017 | 2.96B | 285.69% |
| Dec 30, 2016 | 766.50M | 7.38% |
| Dec 31, 2015 | 713.80M | 52.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |